Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

Zielinski, Christoph, Láng, István, Beslija, Semir, Kahán, Zsuzsanna, Inbar, Moshe J., Stemmer, Salomon M., Anghel, Rodica, Vrbanec, Damir, Messinger, Diethelm, Brodowicz, Thomas: Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer.
BRITISH JOURNAL OF CANCER, 114. pp. 163-170. ISSN 0007-0920 (2016)

[img]
Preview
Text
bjc2015419a.pdf - Published Version

Download (273kB) | Preview
Item Type: Article
Journal or Publication Title: BRITISH JOURNAL OF CANCER
Date: 2016
Volume: 114
Page Range: pp. 163-170
ISSN: 0007-0920
Faculty: Faculty of Medicine
Institution: Szegedi Tudományegyetem
MTMT id: 2992639
DOI id: https://doi.org/10.1038/bjc.2015.419
Date Deposited: 2017. Aug. 30. 11:57
Last Modified: 2020. Jan. 17. 15:00
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/11867
Web of Science® Times Cited: 7 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year